Abstract
Applications for gene therapy that depend upon localization and control of gene expression are challenged by the mode for gene delivery. Viral vectors inherently suffer spread of the viral particles, as does liposome-based gene transfer. Similarly conventional “open-field” electroporation (OFE) achieves gene electrotransfer of naked plasmid DNA injected generally into the target tissue by means of a brief train of high-voltage electrical pulses creating a quasi-uniform electric field. The targeting of the gene transfer with OFE can be controlled to some extent by the placement of the electrodes in the tissue and the volume of injected DNA. In this chapter the application of “close-field” electroporation (CFE) is described, where a gene delivery probe is used for highly localized and controlled gene electrotransfer. CFE arose from use of cochlear implant electrode arrays, designed for spatially constrained electrical stimulation of the primary auditory neurons in the cochlea, where the array was reconfigured to provide electric field focusing that produced electric field strengths sufficient for gene delivery in the domain close to the bionic array using applied voltages considerably below that normally required for conventional electroporation. CFE has proved to be a highly robust and efficient means for targeting small tissue regions (hundreds of um2 – to several mm2) for efficient gene delivery, where the shape of the region of the tissue targeted for gene delivery can be controlled by varying the electric field shape around the bionic array and where near “dial-up” control of the delivery of the DNA payload can be achieved by varying the pulse parameters. The CFE gene electrotransfer platform has been successful in establishing a proof of principle for local neurotrophin gene therapy in the cochlea that regenerates primary auditory neuron dendrites in a deafened animal model, improving cochlear implant performance for hearing. The ability to control the distribution of the electric field around the bionic electrode array to deliver titrated local gene electrotransfer suggests that CFE could have broad application for gene therapy.
Conflict of Interest
Three patent filings are associated with this research: (i) Title: Method of providing agents to the cochlea. Inventor: GD Housley. Filing status: National Phase Examination – Europe (application no. 10799287.7; filing date 5 July 2010), United States (application no. 14/145,673; approved 26th August 2016). Assignee: NewSouth Innovations Pty Limited. (ii) Title: Method and apparatus for close-field electroporation. Inventor: GD Housley, M Klugmann, J Pinyon. Filing status: Provisional, Australia (application no. 2013902263; filed 21 June 2013). Assignee: NewSouth Innovations Pty Limited. (iii) Title: Electroporation system for controlled localized therapeutics delivery. Inventor: GD Housley, NH Lovell. Filing status: Australian Provisional Patent filing (application no. 2015902456; filing date 25 June 2015). Assignee: NewSouth Innovations Pty Limited.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Browne CJ, Pinyon JL, Housley DM, Crawford EN, Lovell NH, Klugmann M, Housley GD (2016) Mapping of bionic array electric field focusing in plasmid DNA-based gene electrotransfer. Gene Ther 23:369–379. doi:10.1038/gt.2016.8
Burgain-Chain A, Scherman D (2013) DNA electrotransfer: an effective tool for gene therapy, gene therapy – tools and potential applications. In: Molina FM (ed) Gene therapy – tools and potential applications. InTech, Croatia doi:10.5772/52528
Clark GM, Clark JC, Furness JB (2013) The evolving science of cochlear implants. JAMA 310:1225–1226. doi:10.1001/jama.2013.278142
Golzio M, Rols M (2016) Nucleic acid electrotransfer in mammalian cells: mechanistic description. In: Miklavčič D (ed) Handbook of electroporation. Springer International Publishing, Switzerland doi:10.1007/978-3-319-26779-1
Greenwood D et al (2007) P2X receptor signaling inhibits BDNF-mediated spiral ganglion neuron development in the neonatal rat cochlea. Development 134:1407–1417
Heller LC (2016) Principles of electroporation for gene therapy. In: Miklavčič D (ed) Handbook of electroporation. Springer International Publishing, Switzerland doi:10.1007/978-3-319-26779-1
Heller LC, Heller R (2010) Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther 10:312–317
Heller R, Jaroszeski MJ, Gilbert R (2011) Electroporation system and method for facilitating entry of molecules into cells in vivo. US Patent no. 7,879,610. U.S.A. Patent
Housley GD (2016) Method of providing agents to the cochlea. US Patent application no. 14/145,673 (approved). United States of America Patent
Khalili Moghadam G, Wilke R, Suaning GJ, Lovell NH, Dokos S (2013) Quasi-monopolar stimulation: a novel electrode design configuration for performance optimization of a retinal neuroprosthesis. PLoS One 8:e73130. doi:10.1371/journal.pone.0073130
O’Leary SJ, Richardson RR, McDermott HJ (2009) Principles of design and biological approaches for improving the selectivity of cochlear implant electrodes. J Neural Eng 6:055002. doi:S1741-2560(09)05488-3 [pii]
Pinyon JL (2016) Enhancing the bionic ear through close-field electroporation gene therapy UNSW Australia Ph.D. thesis
Pinyon JL et al (2014a) Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear. Sci Transl Med 6:233ra254. doi:10.1126/scitranslmed.3008177
Pinyon JL et al (2014b) Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear (supplementary information). Sci Transl Med 6(233):233ra54. doi:10.1126/scitranslmed.3008177
Rebersek M, Faurie C, Kanduser M, Corovic S, Teissie J, Rols MP, Miklavcic D (2007) Electroporator with automatic change of electric field direction improves gene electrotransfer in-vitro. Biomed Eng Online 6:25, 1475-925X-6-25 [pii]
Richardson RT et al (2009) Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 30:2614–2624
Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D, Mir LM (2002) Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 5:133–140. doi:10.1006/mthe.2002.0526
Wise AK et al (2010) Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea. Mol Ther 18:1111–1122. doi:10.1038/mt.2010.28
Yandell K (2014) Hearing help. Scientist 29(9):43–49, http://www.the-scientist.com/?articles.view/articleNo/43819/title/Hearing-Help/
Zeng FG, Tang Q, Lu T (2014) Abnormal pitch perception produced by cochlear implant stimulation. PLoS One 9:e88662. doi:10.1371/journal.pone.0088662
Acknowledgments
Dr. Amr Al Abed is thanked for the electric field modeling shown in Fig. 12. Funded by an Australian Research Council Discovery Grant (DP151014754). All data derived from animal experiments followed protocols approved by the UNSW Animal Care and Ethics Committee.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Housley, G.D., Browne, C.J., Crawford, E.N., Klugmann, M., Lovell, N.H., Pinyon, J.L. (2017). Cochlear Implant Close-Field Electroporation. In: Miklavčič, D. (eds) Handbook of Electroporation. Springer, Cham. https://doi.org/10.1007/978-3-319-32886-7_59
Download citation
DOI: https://doi.org/10.1007/978-3-319-32886-7_59
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32885-0
Online ISBN: 978-3-319-32886-7
eBook Packages: EngineeringReference Module Computer Science and Engineering
